COMP <GO>
NGVT vs FCX // NET PROFIT MARGIN
Ingevity Corporation (NYSE) VS. Freeport-McMoRan Inc. (NYSE) • 15-METRIC TALLY: NGVT 6
— FCX 6
▲ NET PROFIT MARGIN LEADER: FCX
LAST: $75.37 (+1.62%) • MKT CAP: $2.59B
net-margins
-14.30%
LAST: $66.14 (-0.69%) • MKT CAP: $94.98B
net-margins
8.80%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (NGVT VS. FCX)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | NGVT | FCX | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 39.50% | 26.10% | +13.40 | NGVT | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 85.00% | 21.50% | +63.50 | NGVT | /roic <GO> |
| EV/EBITDA & P/E Valuation | 6.0x | 13.4x | -7.40 | NGVT | /valuation <GO> |
| Free Cash Flow Yield | 12.78% | 4.71% | +8.07 | NGVT | /fcf-yield <GO> |
| Operating Margin | 35.90% | 25.90% | +10.00 | NGVT | /operating-margins <GO> |
| Net Profit Margin ACTIVE | -14.30% | 8.80% | -23.10 | FCX | /net-margins <GO> |
| Revenue Growth (YoY) | -2.70% | 0.10% | -2.80 | FCX | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.91% | -0.91 | FCX | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 2.93 | 3.08 | -0.15 | FCX | /balance-sheet <GO> |
| Piotroski F-Score Quality | 6/9 | 7/9 | -1.00 | FCX | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 65.2 | 43.5 | +21.70 | NGVT | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 0.95 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 40.1x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $2.59B | $94.98B | -$92.39B | FCX | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | NGVT REV | FCX REV | NGVT GROSS % | FCX GROSS % | NGVT FCF | FCX FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $1.17B | $25.19B | 39.5% | 26.1% | $331.2M | $4.48B |
| FY 2024 | $1.20B | $25.17B | 38.7% | 29.3% | $128.6M | $6.03B |
| FY 2023 | $1.22B | $22.70B | — | — | $205.1M | $4.26B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
NGVT // BETA —
FCX // BETA 0.95